KAM
JNCE

Knightsbridge Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Knightsbridge Asset Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,542
Closed -$25K – 140
2023
Q1 		$25K Buy
+13,542
New +$25K ﹤0.01% 128